L-745,870
(Preusmjereno sa stranice OGJGQVFWEPNYSB-UHFFFAOYSA-N)
L-745,870 je lek koji deluje kao dopaminski antagonist. On je selektivni parcijalni agonist D4 podtipa. L-745,870 ima antipsihotično dejstvo u životinjskim modelima. On nije pokazao taj efekat u kliničkim ispitivanjima.[3][4][5]
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| 3-([4-(4-hlorofenil)piperazin-1-il]metil)-1H-pirolo[2,3-b]piridin | |||
| Klinički podaci | |||
| Identifikatori | |||
| CAS broj | 158985-00-3 | ||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 5311200 | ||
| Hemijski podaci | |||
| Formula | C18H19ClN4 | ||
| Mol. masa | 326,822 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR (June 1997). „Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist”. Trends in Pharmacological Sciences 18 (6): 186–8. PMID 9226994.
- ↑ Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ (September 2004). „Regulation of working memory by dopamine D4 receptor in rats”. Neuropsychopharmacology 29 (9): 1648–55. DOI:10.1038/sj.npp.1300491. PMID 15138447.
- ↑ Moustgaard A, Hau J, Lind NM (2008). „Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats”. Behavioral and Brain Functions 4: 49. DOI:10.1186/1744-9081-4-49. PMC 2577092. PMID 18945334.
